Literature DB >> 11096520

Cor Pulmonale.

.   

Abstract

The goals of treatment of cor pulmonale are 1) to reduce pulmonary arterial hypertension; 2) to optimize gas-exchange efficiency; and 3) to improve survival. These goals are achieved through long-term oxygen therapy, bronchodilator and vasodilator therapy, aggressive treatment of pulmonary infection, and anticoagulation. Selected patients may benefit from available surgical options.

Entities:  

Year:  2000        PMID: 11096520     DOI: 10.1007/s11936-000-0008-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  65 in total

1.  Overnight decrease in hematocrit after nasal CPAP treatment in patients with OSA.

Authors:  J Krieger; E Sforza; M Barthelmebs; J L Imbs; D Kurtz
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

2.  The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.

Authors:  M Wanecek; A Rudehill; A Hemsén; J M Lundberg; E Weitzberg
Journal:  Crit Care Med       Date:  1997-05       Impact factor: 7.598

3.  Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.

Authors:  N S Hill; R R Warburton; L Pietras; J R Klinger
Journal:  J Appl Physiol (1985)       Date:  1997-10

4.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

Review 5.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

6.  Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale.

Authors:  H Singh; M J Ebejer; D A Higgins; A H Henderson; I A Campbell
Journal:  Thorax       Date:  1985-12       Impact factor: 9.139

Review 7.  Role of pharmacologic tests in the treatment of primary pulmonary hypertension.

Authors:  N Galiè; G Ussia; P Passarelli; R Parlangeli; A Branzi; B Magnani
Journal:  Am J Cardiol       Date:  1995-01-19       Impact factor: 2.778

8.  Predictors of survival in patients treated with long-term oxygen therapy.

Authors:  W MacNee
Journal:  Respiration       Date:  1992       Impact factor: 3.580

9.  Low-dose dopamine in severe right heart failure and chronic obstructive pulmonary disease.

Authors:  T Y Chan
Journal:  Ann Pharmacother       Date:  1995-05       Impact factor: 3.154

10.  Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans.

Authors:  D G Kiely; R I Cargill; B J Lipworth
Journal:  Chest       Date:  1996-09       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.